Pfm Health Sciences, LP Biogen Inc. Call Options Transaction History

Pfm Health Sciences, LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $32.5 Million - $44.8 Million	166,800 New	166,800 $44.5 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $30.6 Million - $46.1 Million	129,700 Added 428.05%	160,000 $39.2 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $6.67 Million - $9.21 Million	30,300 New	30,300 $8.99 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.